George Washington University Cancer Center — Washington D.C., District of Columbia

George Washington University Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

George Washington University Cancer Center has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, HIV-Associated Malignant Neoplasm, HIV Infections.

Sponsors: Celgene, AIDS Malignancy Consortium, George Washington University.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for George Washington University Cancer Center?

George Washington University Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has George Washington University Cancer Center conducted?

George Washington University Cancer Center has 9 clinical trials on record, with 3 currently active. Their work covers Leukemia, Myeloid, Acute, HIV-Associated Malignant Neoplasm, HIV Infections.

Is George Washington University Cancer Center accredited by Crixeo Health?

Yes — George Washington University Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about George Washington University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.